Research: Making the biotech IPO work

There were more biotech IPOs in 2012-13 than in a y previous IPO window. Will these companies be able to deliver of their promise of new generations of therapeutic products and economic growth? A recent paper from the Center for Integration of Science and Industry provides a prescription for success that will require strategic business models and patience. Listen to interview on Bloomberg Radio.

Sticky Post: